Related Experiment Video
Updated: Apr 28, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
New clues to understanding HIV nonprogressors: low cholesterol blocks HIV trans infection
Vinayaka R Prasad1, Michael I Bukrinsky2
1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA vinayaka.prasad@einstein.yu.edu mbukrins@gwu.edu.
Abstract:
A small percentage of HIV-infected subjects (2 to 15%) are able to control disease progression for many years without antiretroviral therapy. Years of intense studies of virologic and immunologic mechanisms of disease control in such individuals yielded a number of possible host genes that could be responsible for the preservation of immune functions, from immune surveillance genes, chemokines, or their receptors to anti-HIV restriction factors. A recent mBio paper by Rappocciolo et al. (G. Rappocciolo, M. Jais, P. Piazza, T. A. Reinhart, S. J. Berendam, L. Garcia-Exposito, P. Gupta, and C. R. Rinaldo, mBio 5:e01031-13, 2014) describes another potential factor controlling disease progression: cholesterol levels in antigen-presenting cells. In this commentary, we provide a brief background of the role of cholesterol in HIV infection, discuss the results of the study by Rappocciolo et al., and present the implications of their findings.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Cholesterol: Significance and Regulation
Considering cholesterol and...
Retroviruses
Inhibitors of Viral Protein Synthesis
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

